Evidence map›Paper›PMID 40045583›Full record

ArticleEpidemiology and health2025

Preventable cancer cases and deaths attributable to tobacco smoking in Korea from 2015 to 2030.

Soseul Sung, Jihye An, Jeehi Jung, Hyeon Sook Lee, Sungji Moon, Inah Kim, Jung Eun Lee, Aesun Shin, Sun Ha Jee, Sun-Seog Kweon and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Soseul SungDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Jihye AnDepartment of Epidemic Intelligence Service, Incheon Communicable Diseases Center, Incheon, Korea.
Jeehi JungDepartment of Biomedicine & Health Science, The Catholic University of Korea, Seoul, Korea.
Hyeon Sook LeeIncheon Public Health Policy Institute, Incheon, Korea.
Sungji MoonDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Inah KimDepartment of Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, Korea.
Jung Eun LeeDepartment of Food and Nutrition, Seoul National University, Seoul, Korea.
Aesun ShinDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Sun Ha JeeDepartment of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea.
Sun-Seog KweonDepartment of Preventive Medicine, Chonnam National University Medical School, Hwasun, Korea.
Min-Ho ShinDepartment of Preventive Medicine, Chonnam National University Medical School, Hwasun, Korea.
Sangmin ParkDepartment of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
Seungho RyuDepartment of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Sun Young YangDepartment of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Seung Ho ChoiDepartment of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Jeongseon KimGraduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Sang-Wook YiDepartment of Preventive Medicine and Public Health, Catholic Kwandong University College of Medicine, Gangneung, Korea.
Yoon-Jung ChoiGraduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Youjin HongDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Sangjun LeeDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Woojin LimDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kyungsik KimDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Daehee KangDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Keun-Young YooDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Sohee ParkDepartment of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea.
Jeong-Soo ImDivision of Cancer Registration and Surveillance, National Cancer Center, Goyang, Korea.
Hong Gwan SeoGraduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Hai-Rim ShinDivision of Healthy Environments and Population, Western Pacific Regional Office, World Health Organization, Manila, Philippines.
Kwang-Pil KoDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Sue K ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.

Funding

NIEHS NIH HHS 27303C0140
6 · The paper itself

Abstract

objectivesTobacco smoking is a major public health concern worldwide. This study aimed to assess its impact on cancer incidence and mortality by estimating the population attributable fraction (PAF) in the Korean population for 2015 and 2020 and by projecting future trends until 2030.

methodsThe Korean relative risk (RR) was calculated via a meta-analysis of RRs for individual cancers attributed to tobacco smoking, based on primary data analysis from the Korean Cohort Consortium. The PAF was estimated using the Levin formula with past and current prevalence rates and the number of cancer cases and deaths, assuming a 15-year latency period.

resultsThe proportions of cancer cases and deaths in Korea attributable to tobacco smoking were similar to those calculated using Asian and global RRs for both male and female. In 2015 and 2020, tobacco smoking contributed to 14.32% and 13.17% of cancer cases and 21.70% and 20.69% of cancer deaths in adults, respectively. Among Koreans, smoking was responsible for 25.83% of new cancer cases in male in 2015, 23.49% in male in 2020, 1.46% in female in 2015, and 1.68% in female in 2020. In both years, smoking impacted mortality more strongly than incidence in Korean male and female (incidence in male: 25.83% and 23.49%; mortality in male: 32.09% and 30.41%; incidence in female: 1.46% and 1.68%; and mortality in female: 4.70% and 4.96%, respectively).

conclusionsTobacco smoking causes cancers and deaths in Korea, however, it is preventable. Effective control policies that consider trends and vulnerabilities among female are required.

Indexed as

NeoplasmsTobacco SmokingAdultAgedFemaleHumansIncidenceMaleMiddle AgedRepublic of KoreaYoung AdultEpidemiologyKoreaNeoplasmsPopulation attributable fractionSmoking

Identifiers

PMID40045583
PMCPMC12531467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.